[Uncomplicated acute male and female gonorrhea: treatment with a single oral dose of epicillin-probenecid].

We treated 142 patients with acute uncomplicated gonorrhea with a single oral dose of epiciline-probenecid. All cases were confirmed by culture on Thayer Martin medium at the first day and they were all laboratory tested seven days after treatment. At the control time the patients were asked about drug tolerance. All isolated strains were tested for beta-lactamase producing capacity and susceptibility to epiciline and penicillin. All patients who were culture positive seven days after treatment were considered to be treatment failures. The treatment was effective in 94.4% and we detected 8 Neisseria gonorrhoeae strains resistant to penicillin (5.6%); seven of these were PPNG strains. Tolerance to the drug was excellent in 90% of all cases; 9% presented minor adverse reactions for a short period of time. Therefore, the combination of epiciline-probenecid is a valid alternative for routine treatment of acute uncomplicated gonorrhea.
AuthorsA Salvo, A Maldonado, J García, A Leone, B Rojas, I Riedel
JournalRevista meĢdica de Chile (Rev Med Chil) Vol. 117 Issue 4 Pg. 406-10 (Apr 1989) ISSN: 0034-9887 [Print] CHILE
Vernacular TitleGonorrea aguda masculina y femenina no complicada: tratamiento con dosis única oral de epicilina-probenecid.
PMID2519394 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Drug Combinations
  • Ampicillin
  • Probenecid
  • Acute Disease
  • Administration, Oral
  • Adolescent
  • Adult
  • Ampicillin (therapeutic use)
  • Ampicillin Resistance
  • Drug Combinations
  • Female
  • Gonorrhea (drug therapy)
  • Humans
  • Male
  • Probenecid (therapeutic use)
  • Urethritis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: